Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs

Bone fractures related to musculoskeletal disorders determine long-term disability in older people with a consequent significant economic burden. The recovery of pathologically impaired tissue architecture allows avoiding bone loss-derived consequences such as bone height reduction, deterioration of...

Full description

Bibliographic Details
Main Authors: Ines Fasolino, Alessandra Soriente, Luigi Ambrosio, Maria Grazia Raucci
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/9/1743
id doaj-904baf88c74346c4901303266d145317
record_format Article
spelling doaj-904baf88c74346c4901303266d1453172020-11-25T03:21:26ZengMDPI AGNanomaterials2079-49912020-09-01101743174310.3390/nano10091743Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic DrugsInes Fasolino0Alessandra Soriente1Luigi Ambrosio2Maria Grazia Raucci3Institute of Polymers, Composites and Biomaterials—National Research Council (IPCB-CNR), Mostra d’Oltremare pad.20—Viale J.F. Kennedy 54, 80125 Naples, ItalyInstitute of Polymers, Composites and Biomaterials—National Research Council (IPCB-CNR), Mostra d’Oltremare pad.20—Viale J.F. Kennedy 54, 80125 Naples, ItalyInstitute of Polymers, Composites and Biomaterials—National Research Council (IPCB-CNR), Mostra d’Oltremare pad.20—Viale J.F. Kennedy 54, 80125 Naples, ItalyInstitute of Polymers, Composites and Biomaterials—National Research Council (IPCB-CNR), Mostra d’Oltremare pad.20—Viale J.F. Kennedy 54, 80125 Naples, ItalyBone fractures related to musculoskeletal disorders determine long-term disability in older people with a consequent significant economic burden. The recovery of pathologically impaired tissue architecture allows avoiding bone loss-derived consequences such as bone height reduction, deterioration of bone structure, inflamed bone pain, and high mortality for thighbone fractures. Actually, standard therapy for osteoporosis treatment is based on the systemic administration of biphosphonates and anti-inflammatory drugs, which entail several side effects including gastrointestinal (GI) diseases, fever, and articular pain. Hence, the demand of innovative therapeutic approaches for locally treating bone lesions has been increasing in the last few years. In this scenario, the development of injectable materials loaded with therapeutically active agents (i.e., anti-inflammatory drugs, antibiotics, and peptides mimicking growth factors) could be an effective tool to treat bone loss and inflammation related to musculoskeletal diseases, including osteoporosis and osteoarthritis. According to this challenge, here, we propose three different compositions of injectable calcium phosphates (CaP) as new carrier materials of therapeutic compounds such as bisphosphonates (i.e., alendronate), anti-inflammatory drugs (i.e., diclofenac sodium), and natural molecules (i.e., harpagoside) for the local bone disease treatment. Biological quantitative analyses were performed for screening osteoinductive and anti-inflammatory properties of injectable drug-loaded systems. Meanwhile, cell morphological features were analyzed through scanning electron microscopy and confocal investigations. The results exhibited that the three systems exerted an osteoinductive effect during later phases of osteogenesis. Simultaneously, all compositions showed an anti-inflammatory activity on inflammation in vitro models.https://www.mdpi.com/2079-4991/10/9/1743injectable biomaterialsbone tissue regenerationcalcium phosphatesinflammation treatmentdrug loaded biomaterialssol-gel method and in vitro model
collection DOAJ
language English
format Article
sources DOAJ
author Ines Fasolino
Alessandra Soriente
Luigi Ambrosio
Maria Grazia Raucci
spellingShingle Ines Fasolino
Alessandra Soriente
Luigi Ambrosio
Maria Grazia Raucci
Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
Nanomaterials
injectable biomaterials
bone tissue regeneration
calcium phosphates
inflammation treatment
drug loaded biomaterials
sol-gel method and in vitro model
author_facet Ines Fasolino
Alessandra Soriente
Luigi Ambrosio
Maria Grazia Raucci
author_sort Ines Fasolino
title Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
title_short Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
title_full Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
title_fullStr Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
title_full_unstemmed Osteogenic and Anti-Inflammatory Behavior of Injectable Calcium Phosphate Loaded with Therapeutic Drugs
title_sort osteogenic and anti-inflammatory behavior of injectable calcium phosphate loaded with therapeutic drugs
publisher MDPI AG
series Nanomaterials
issn 2079-4991
publishDate 2020-09-01
description Bone fractures related to musculoskeletal disorders determine long-term disability in older people with a consequent significant economic burden. The recovery of pathologically impaired tissue architecture allows avoiding bone loss-derived consequences such as bone height reduction, deterioration of bone structure, inflamed bone pain, and high mortality for thighbone fractures. Actually, standard therapy for osteoporosis treatment is based on the systemic administration of biphosphonates and anti-inflammatory drugs, which entail several side effects including gastrointestinal (GI) diseases, fever, and articular pain. Hence, the demand of innovative therapeutic approaches for locally treating bone lesions has been increasing in the last few years. In this scenario, the development of injectable materials loaded with therapeutically active agents (i.e., anti-inflammatory drugs, antibiotics, and peptides mimicking growth factors) could be an effective tool to treat bone loss and inflammation related to musculoskeletal diseases, including osteoporosis and osteoarthritis. According to this challenge, here, we propose three different compositions of injectable calcium phosphates (CaP) as new carrier materials of therapeutic compounds such as bisphosphonates (i.e., alendronate), anti-inflammatory drugs (i.e., diclofenac sodium), and natural molecules (i.e., harpagoside) for the local bone disease treatment. Biological quantitative analyses were performed for screening osteoinductive and anti-inflammatory properties of injectable drug-loaded systems. Meanwhile, cell morphological features were analyzed through scanning electron microscopy and confocal investigations. The results exhibited that the three systems exerted an osteoinductive effect during later phases of osteogenesis. Simultaneously, all compositions showed an anti-inflammatory activity on inflammation in vitro models.
topic injectable biomaterials
bone tissue regeneration
calcium phosphates
inflammation treatment
drug loaded biomaterials
sol-gel method and in vitro model
url https://www.mdpi.com/2079-4991/10/9/1743
work_keys_str_mv AT inesfasolino osteogenicandantiinflammatorybehaviorofinjectablecalciumphosphateloadedwiththerapeuticdrugs
AT alessandrasoriente osteogenicandantiinflammatorybehaviorofinjectablecalciumphosphateloadedwiththerapeuticdrugs
AT luigiambrosio osteogenicandantiinflammatorybehaviorofinjectablecalciumphosphateloadedwiththerapeuticdrugs
AT mariagraziaraucci osteogenicandantiinflammatorybehaviorofinjectablecalciumphosphateloadedwiththerapeuticdrugs
_version_ 1724614820296130560